The FDA Is Just Catching Up
Nogueira, Acute pancreatitis due to different semaglutide regimens: An updated meta-analysis, Endocrinologa, Diabetes y Nutricin, Volume 71, Issue 3, 2024, Pages 124-132, ISSN 2530-0164, 3- Deanfield J, Verma S, Scirica BM, Kahn SE, Emerson SS, Ryan D, Lingvay I, Colhoun HM, Plutzky J, Kosiborod MN, Hovingh GK, Hardt-Lindberg S, Frenkel O, Weeke PE, Rasmussen S, Goudev A, Lang CC, Urina-Triana M, Pietil M, Lincoff AM
In every aspect of medicine, when there is metabolic signaling dysfunction, we call that a disease
Others argue that as long as high-cost drugs exist, utilization management (UM) is necessary, and ePA is the ethical approach to implement UM transparently and fairly